Akanda Corp.

NasdaqCM AKAN

Akanda Corp. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 2,404.33%

Akanda Corp. Return on Capital Employed (ROCE) is 2,404.33% for the year ending December 31, 2023, a 8,878.95% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.
  • Akanda Corp. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was -27.39%, a -102.47% change year over year.
  • Akanda Corp. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 1,107.43%.
Key data
Date Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio Return on Common Equity
Market news
Loading...
NasdaqCM: AKAN

Akanda Corp.

CEO Ms. Katharyn Field
IPO Date March 15, 2022
Location United Kingdom
Headquarters 1a, 1b Learoyd Road
Employees 46
Sector Health Care
Industries
Description

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Similar companies

SNOA

Sonoma Pharmaceuticals, Inc.

USD 2.64

2.33%

LFCR

Lifecore Biomedical, Inc.

USD 6.43

1.10%

BFRI

Biofrontera Inc.

USD 1.05

-7.08%

DERM

Journey Medical Corporation

USD 3.73

-1.32%

StockViz Staff

January 15, 2025

Any question? Send us an email